NDC 71656-071-08 - Tofacitinib
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71656-071
- Requested NDC
- 71656-071-08
- Package NDCs from labels
- 71656-071-08
- Manufacturer
- Saptalis Pharmaceuticals, LLC.
- Effective date
- 2026-10-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tofacitinib - Saptalis Pharmaceuticals, LLC. | Saptalis Pharmaceuticals, LLC. | 2026-10-15 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BEVERHILL HAIR TONIC | UNDARIA PINNATIFIDA EXTRACT, CAMELLIA SINENSIS LEAF EXTRACT, MORUS ALBA BARK EXTRACT, PINUS DENSIFLORA LEAF EXTRACT, ARTEMISIA VULGARIS EXTRACT, SESAMUM INDICUM SEED EXTRACT, SODIUM BENZOATE | BIOHERB Co., Ltd. | 32733977-606e-f110-e063-6294a90aba8f | 2026-11-06 | Warnings | OJ245FE5EU |
| Tofacitinib | TOFACITINIB | XLCare Pharmaceuticals Inc | 10403307-e2f9-44d1-bc72-552fdba299d1 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Macleods Pharmaceuticals Limited | 9b654f0d-7705-4880-9e9d-ad3a51e56b56 | 2026-10-22 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | Stellon Biotech Inc. | 89eb2ffc-02d9-4b46-b480-e9b10af33027 | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Sun Pharmaceutical Industries, Inc. | a764a133-b870-4514-bbee-24d43f8cb7fd | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | 2478433 O1FF4DIV0D |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | CONCORD BIOTECH LIMITED | 6c33e5b4-4843-4a80-a4f8-435bfceddc2a | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Saptalis Pharmaceuticals, LLC. | c6c033ff-bce0-4d1c-a182-3b13191686e1 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | ANDA218900 71656-071-08 71656-071 71656007108 2478433 5de6efa2-e9c7-b0cc-e063-6294a90ac8da c6c033ff-bce0-4d1c-a182-3b13191686e1 O1FF4DIV0D |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | Golden State Medical Supply, Inc. | 5dd43533-dadc-2acb-e063-6394a90a413f | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 179ffbb2-bedc-40e6-b77b-33d4f7832172 | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Apotex Corp. | dd62a2b8-300b-d92b-7b27-a30eaa68fdd3 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Tofacitinib XR | TOFACITINIB | Biocon Pharma Inc | f0160e3d-63ea-75fb-4b88-fe3d6a6ce030 | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| XELJANZ | TOFACITINIB | U.S. Pharmaceuticals | 68e3d6b2-7838-4d2d-a417-09d919b43e13 | 2026-10-06 | Boxed warning, Warnings, Adverse reactions | 2478433 O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Ajanta Pharma USA Inc. | 024bb9f2-8c26-4d9d-a33b-eb3c0a7c59ed | 2026-10-05 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 21a89264-8047-40ac-8b10-fa6461072509 | 2026-10-05 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Bryant Ranch Prepack | 89211a4d-befb-40f1-8792-aa599fdd794c | 2026-10-02 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Micro Labs Limited | ffa6819b-23a4-478b-8fb7-cc90e8142fc5 | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| tofacitinib solution | TOFACITINIB | Hikma Pharmaceuticals USA Inc. | d9cf18a9-e825-49ac-b080-68957c0e79ae | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | 2478433 O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Novadoz Pharmaceuticals LLC | 253635c8-1ea7-41ba-b216-dea5e3305c47 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Novadoz Pharmaceuticals LLC | 327f6b60-1a5d-49e6-acff-18603d0ee9d0 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | 2478433 O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Edenbridge Pharmaceuticals LLC. | 576722e5-6639-452d-a5c3-33a064f19481 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.